Coral #33 Joint Venture
Coral #33 Joint Venture is an energy fund based in Boca Raton, Florida. According to its most recent Form D, filed Apr 10, 2009, it has sold $900,775 of interests to 23 investors since its first sale in Dec 2008. The minimum investment it accepts from an outside investor is $18,812. Related persons named in the filing include Dan Beecroft; Jon Berman; Phil Barnett.
- Total raised
- $900,775Cumulative sales reported on Form D
- Investors
- 23
- First sale
- Dec 31, 2008
- Minimum investment
- $18,812
- Who can invest
- Not stated
- Offering exemption
- Other exemption
- Key people and entities
- Dan Beecroft; Jon Berman; Phil Barnett
- Latest Form D
- Apr 10, 2009
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Coral #33 Joint Venture
What is the minimum investment for Coral #33 Joint Venture?
According to its latest Form D, filed Apr 10, 2009, the minimum investment Coral #33 Joint Venture accepts from an outside investor is $18,812.
Who can invest in Coral #33 Joint Venture?
Coral #33 Joint Venture is generally open only to investors who meet the eligibility rules in its offering documents.
How much has Coral #33 Joint Venture raised?
Coral #33 Joint Venture reports $900,775 sold from 23 investors on its Form D filed Apr 10, 2009. This is cumulative sales since the offering began, not current assets or performance.
Where is Coral #33 Joint Venture based?
Coral #33 Joint Venture is based in Boca Raton, Florida.
When did Coral #33 Joint Venture launch?
Coral #33 Joint Venture reports its first sale in Dec 2008.
Size compared with every energy fund
Raised more than 56% of the 9 energy funds based in Florida, and more than 38% of all 331 that report sales.